002262 Jiangsu Nhwa Pharmaceutical
- 26.00
- -0.35-1.33%
About Jiangsu Nhwa Pharmaceutical Company
The company was founded in 1978 and listed on the Shenzhen Stock Exchange in 2008. It is a pharmaceutical enterprise integrating science, industry and trade. The company's main business is pharmaceutical research and development, production and sales. Pharmaceutical sales include sales of raw materials and preparations produced by the company, as well as pharmaceutical wholesale and retail business. The company's main products are the manufacture and manufacture of central nervous system products (including anesthetic, psychotropic and neurological pharmaceutical raw materials and their preparations). Corporate honors: Jiangsu Green Factory, National Advanced Employment and Social Security Private Enterprise, Tax Credit Class A Enterprise, “AAA” Credit Rating Certificate issued by Jiangsu Zhongchengxin Credit Management Co., Ltd., “Five-star Brand Certification” and “Five-star After-sales Service Certification” issued by Beijing Huayuan Runze International Certification Co., Ltd., ranked 85th in the 2023 China Pharmaceutical Industry Top 100 Enterprises, selected for the 2021 Jiangsu Top Ten Corporate Social Responsibility Construction Industry List, “Environmental Management System Certification” issued by the China Quality Certification Center, China Quality Certification Center in 2023 Pharmaceutical research and development strength ranked 26th, ranked 43rd in the 2023 Jiangsu Private Enterprise Innovation Top 100, Xuzhou's first batch of environmental protection demonstration enterprises in 2023, and excellent quality management enterprises in the pharmaceutical industry in Jiangsu Province in 2023.
Company Profile
Company Executives
- Name
- Position
- Salary
- pengsheng sun
- Chairman, Directors, Chairman of the Strategy Committee
- 250.00K
- qing fu
- Directors, Deputy General Manager, Nomination Committee Members
- 200.00K
- jiaquan sun
- Directors, General Manager, Strategy Committee Member
- 4.80M
- ziliang yang
- Directors, Deputy General Manager, Member of the Remuneration and Assessment Committee
- 200.00K
- zengliang chen
- Directors, Deputy General Manager
- 200.00K
- xiaoxing yin
- Independent Directors, Strategy Committee Member, Chairman of the Nomination Committee, Audit Committee Members
- 50.00K
- yulan li
- Independent Directors, Audit Committee Member, Chairman of the Remuneration and Assessment Committee, Nomination Committee Members
- 50.00K
- guangji wang
- Independent Directors, Strategy Committee Member
- 50.00K
- guoxiang chen
- Independent Directors, Member of the Remuneration and Assessment Committee, Strategy Committee Member, Chairman of the Audit Committee
- 50.00K
- baozhou duan
- Board Secretary, Deputy General Manager
- 413.70K
- jiye wu
- Securities Affairs Representative
- --
- fengshou wang
- Chairman of the Supervisory Board, Auditors
- 288.00K
- xinglei jia
- Auditors
- 383.70K
- gangsheng li
- Chief Financial Officer
- 633.60K
- weifang zhang
- Head of Internal Audit
- --
- ying wang
- Head of Internal Audit Department
- --
- xiaochen qian
- Employee Supervisors
- 218.40K
Analysis
Price Target
No Data
No Data